Novartis to Manufacture Mass General's Coronavirus Vaccine Candidate
Published
A subsidiary of the pharmaceutical giant will soon ramp up production of the nonprofit hospital's SARS-CoV-2 vaccine candidate, which has yet to enter human clinical trials.
Full Article